Recordati Industria Chimica e Farmaceutica SpA
MIL:REC

Watchlist Manager
Recordati Industria Chimica e Farmaceutica SpA Logo
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Watchlist
Price: 49.16 EUR -1.25%
Market Cap: 10.3B EUR

Relative Value

The Relative Value of one REC stock under the Base Case scenario is hidden EUR. Compared to the current market price of 49.16 EUR, Recordati Industria Chimica e Farmaceutica SpA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

REC Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
95
vs Industry
26
Median 3Y
4.5
Median 5Y
4.7
Industry
2.7
Forward
3.8
vs History
61
vs Industry
18
Median 3Y
25.6
Median 5Y
25.6
Industry
21.6
Forward
18.9
vs History
76
vs Industry
21
Median 3Y
18.6
Median 5Y
19
Industry
16.9
vs History
66
vs Industry
7
Median 3Y
36.1
Median 5Y
34.8
Industry
22.9
vs History
74
vs Industry
12
Median 3Y
5.6
Median 5Y
5.8
Industry
2.3
vs History
88
vs Industry
24
Median 3Y
5.1
Median 5Y
5.3
Industry
3
Forward
4.6
vs History
82
vs Industry
27
Median 3Y
7.6
Median 5Y
7.7
Industry
5.6
vs History
92
vs Industry
24
Median 3Y
14.9
Median 5Y
15.1
Industry
13.4
Forward
12.2
vs History
82
vs Industry
23
Median 3Y
18.7
Median 5Y
18.9
Industry
16.7
Forward
16
vs History
61
vs Industry
19
Median 3Y
21.6
Median 5Y
21.6
Industry
16.1
vs History
vs Industry
19
Median 3Y
24.6
Median 5Y
24.8
Industry
18.9
vs History
87
vs Industry
23
Median 3Y
2.8
Median 5Y
3
Industry
2

Multiples Across Competitors

REC Competitors Multiples
Recordati Industria Chimica e Farmaceutica SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
10.1B EUR 4.1 24.8 14.2 18
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
504.6B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
270.7B CHF 4.4 28.7 12.2 14.3
UK
AstraZeneca PLC
LSE:AZN
217.2B GBP 5 31.1 109.3 159.9
CH
Novartis AG
SIX:NOVN
218B CHF 4.9 19 12 15.5
US
Merck & Co Inc
NYSE:MRK
271.6B USD 4.2 14.3 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.5 11.5 13.3
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Average P/E: 25
24.8
18%
1.4
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.1
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.3
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.5
3%
5.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IT
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Average EV/EBITDA: 401.4
14.2
12%
1.2
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109.3
10%
10.9
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A